Reflexion Health’s virtual rehab platform VERA
Reflexion Health, a remote monitoring business to help people do physical therapy from home, has hired a chief technology officer with a background steeped in robotics and analytics, according to a news release.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Sudipto Sur will be tasked with advancing Reflexion’s technology platform, including the enhancement of the company’s engineering and digital capabilities and its IT infrastructure, the statement said.
The San Diego-based company hired Sur as it prepares to expand its product offering to help a wider and more diverse patient population, Joseph Smith, Reflexion Health’s CEO, said in the statement.
The company’s VERA platform detects motion and remotely monitors the effectiveness of prescribed physical therapy in real-time. The company’s main focus has been the use of VERA for recovery from hip and knee replacement surgery, particularly to support the bundled payment model. The Centers for Medicare and Medicaid Services launched the Comprehensive Care for Joint Replacement payment model last year. But Reflexion has also worked with partners on cardiac rehab, fractures, and chronic pain.
Sur previously worked for molecular diagnostics company Signal Genetics as chief information officer. He produced cloud-based analytics and billing systems at Signal. He also was president of Anssur Corp, an engineering and software services provider for analytics and medical robotics. He led the development of human computer interface products at Miralex Systems.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
In June, Reflexion Health closed an $18 million Series B round so it could complete the evaluation of its first FDA cleared product. Other priorities included product development, scaling the company’s VERA platform nationally among U.S. healthcare systems, and adding staff.
Smith told MedCity News at the time that the company had grown its staff by 20 percent since the start of the year and was planning to add five more staff.
